Boots gender pay gap data is 5%, less than a third of national average

Boots gender pay gap data is 5%, less than a third of national average

March 26 2018 Boots has published data on its gender pay gap, indicating the pay gap benefits...

Prescription levy to rise to £8.80 from April 1 in England

Prescription levy to rise to £8.80 from April 1 in England

February 28 2018 The single NHS prescription charge will increase 20p to £8.80 per item...

Minister admits less than half of Pharmacy Integration Fund has been spent

Minister admits less than half of Pharmacy Integration Fund has been spent

December 19 2017 There has been a “significant underspend” of funding committed to...

£1m funding for pharmacist prescribing clinics in Scotland confirmed for 2017-18

£1m funding for pharmacist prescribing clinics in Scotland confirmed for 2017-18

September 20 2017 The Scottish Government has confirmed that £1 million will be available...

  • Boots gender pay gap data is 5%, less than a third of national average

    Boots gender pay gap data is 5%, less than a third of national average

    Monday, 26 March 2018 12:43
  • Prescription levy to rise to £8.80 from April 1 in England

    Prescription levy to rise to £8.80 from April 1 in England

    Wednesday, 28 February 2018 19:20
  • Minister admits less than half of Pharmacy Integration Fund has been spent

    Minister admits less than half of Pharmacy Integration Fund has been spent

    Tuesday, 19 December 2017 09:45
  • £1m funding for pharmacist prescribing clinics in Scotland confirmed for 2017-18

    £1m funding for pharmacist prescribing clinics in Scotland confirmed for 2017-18

    Wednesday, 20 September 2017 14:00

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

prescription2March 14 2016

The patient prescription fee will increase 20p to £8.40 per item in England from April 1, the Department of Health has announced.

There will be no changes to prepayment certificate fees, with the three month PPC remaining at £29.10 and the 12 month PPC being £104.00. Fees for wigs and fabric supports will increase overall by 1.7%. The government has also stated: “Prescriptions for e-cigarettes will be charged like any other medication and normal exemption arrangements will apply including for those on low incomes.”

The Prescription Charges Coalition, of which the Royal Pharmaceutical Society is one of 38 members, is calling for people with long-term conditions in England to be exempt from prescription charges as they are disproportionately affected due to their need for ongoing medication.

“The continued rise in the charge for prescriptions forms a barrier year on year for working age people who rely on regular medication to manage long-term conditions,” said the Coalition.

“Research shows that one in three of those with long-term conditions have not collected a prescription because of the cost. This can lead to poorer health, expensive hospital admissions and affect productivity at work. We welcome the fact that the pre-payment certificate cost has been frozen; however many people with fluctuating and long term conditions have told us that this cost can still be prohibitive.”

PSNC is advising pharmacy teams to “look out for their copies of the 2016 Prescription Charge Card being sent with the March edition of Community Pharmacy News (CPN) arriving at community pharmacies later this month.”

Links:

DoH announcement

Ministerial statement and link to new few structure

Parliamentary question

RPS announcement

Prescription Charges Coalition

PSNC statement

Finance News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...